Ironwood Pharmaceuticals Stock
Ironwood Pharmaceuticals Stock
A very strong showing by Ironwood Pharmaceuticals today, with an increase of €0.30 (5.450%) compared to yesterday's price.
We see a rather positive sentiment for Ironwood Pharmaceuticals with 8 Buy predictions and 1 Sell predictions.
With a target price of 18 € there is potential for a 210.34% increase which would mean more than doubling the current price of 5.8 € for Ironwood Pharmaceuticals.
Pros and Cons of Ironwood Pharmaceuticals in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ironwood Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ironwood Pharmaceuticals | 5.450% | 6.422% | -24.675% | -43.137% | -43.137% | -38.947% | - |
| Iovance Biotherapeutics Inc. | -0.550% | -11.212% | -31.823% | -0.317% | 4.867% | -45.322% | - |
| Novocure Ltd | -0.580% | -4.920% | 53.480% | -72.684% | 42.137% | -87.762% | - |
| United Therapeutics | -2.080% | 0.955% | 5.313% | 25.099% | 27.970% | 79.929% | 230.769% |
Comments
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) had its price target lowered by analysts at Craig Hallum from $18.00 to $14.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IRWD provided by MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for IRWD provided by MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) had its price target lowered by analysts at Wells Fargo & Company from $20.00 to $14.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IRWD provided by MarketBeat